Redesign Health · 2 months ago
Managing Director, AI Venture Buyouts
Redesign Health is a global venture and applied technology firm focused on building next-generation healthcare companies. They are seeking a Managing Director, AI Venture Buyouts to lead the full lifecycle of their AI Venture Buyout strategy, which includes sourcing and closing control transactions and driving post-close AI transformation.
Artificial Intelligence (AI)Health CareMedicalSmall and Medium BusinessesVenture Capital
Responsibilities
Lead Redesign’s AI-driven buyout strategy focused on healthcare control investments
Build deal flow through a proprietary network of intermediaries, executives, and operators
Execute transactions end-to-end, overseeing diligence, modeling, and closing mechanics
Partner with AI and operating teams to deploy post-close transformation playbooks
Quantify and communicate impact of AI-driven operating leverage across portfolio companies
Participate in raising capital
Build and lead a high-performing investment team
Qualification
Required
10–15 years in healthcare private equity or growth equity, with experience leading control investments
Proven ability to originate, diligence, and close transactions in the healthcare sector
Strong network across healthcare executives, founders, intermediaries, and strategics
Demonstrated success driving value creation through operational and digital transformation
Experience raising capital and managing institutional investor relationships
Deep interest in how AI, automation, and data reshape cost structures and enterprise value, with strong preference for capabilities using and deploying AI tools
Execution Excellence: Process-oriented and rigorous in managing complex transactions
Influential Communicator: Commands credibility with LPs, boards, and management teams
AI-Powered Investor: Has experience using AI tools to drive a structural advantage in deal sourcing, diligence, and execution
Team Leader: Builds small, AI-native teams that execute with precision and urgency
Track record driving measurable value creation in healthcare portfolio companies
Understands payer–provider dynamics, reimbursement, and healthcare regulation
Company
Redesign Health
Redesign Health is a global venture builder that empowers founders to launch and scale transformative healthcare companies.
Funding
Current Stage
Growth StageTotal Funding
$315MKey Investors
General Catalyst
2022-09-13Series C· $65M
2020-03-25Series Unknown· $250M
Recent News
Company data provided by crunchbase